Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Pulmonary/Respiratory Drug Delivery market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Pulmonary/Respiratory Drug Delivery market. Detailed analysis of key players, along with key growth strategies adopted by Pulmonary/Respiratory Drug Delivery industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
GlaxoSmithKline (UK)
Novartis AG (Switzerland)
Merck & Co, Inc (US)
AstraZeneca plc (UK)
3M (US)
Omron Corporation (Japan)
Boehringer Ingelheim GmbH (Germany)
Sunovion Pharmaceuticals Inc (US)
Teva Pharmaceutical Industries Ltd (Israel)
By Type:
Suspension Aerosol
Solution Aerosol
Dry Powder Formulation
By End-User:
Hospitals
Home Care
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Pulmonary/Respiratory Drug Delivery Market
-
1.3 Market Segment by Type
-
1.3.1 China Pulmonary/Respiratory Drug Delivery Market Size and Growth Rate of Suspension Aerosol from 2016 to 2027
-
1.3.2 China Pulmonary/Respiratory Drug Delivery Market Size and Growth Rate of Solution Aerosol from 2016 to 2027
-
1.3.3 China Pulmonary/Respiratory Drug Delivery Market Size and Growth Rate of Dry Powder Formulation from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Pulmonary/Respiratory Drug Delivery Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 China Pulmonary/Respiratory Drug Delivery Market Size and Growth Rate of Home Care from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Pulmonary/Respiratory Drug Delivery Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Pulmonary/Respiratory Drug Delivery Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Pulmonary/Respiratory Drug Delivery Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Pulmonary/Respiratory Drug Delivery Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Pulmonary/Respiratory Drug Delivery Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Pulmonary/Respiratory Drug Delivery Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Pulmonary/Respiratory Drug Delivery Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Pulmonary/Respiratory Drug Delivery Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Pulmonary/Respiratory Drug Delivery by Major Types
-
3.4.1 Market Size and Growth Rate of Suspension Aerosol
-
3.4.2 Market Size and Growth Rate of Solution Aerosol
-
3.4.3 Market Size and Growth Rate of Dry Powder Formulation
4 Segmentation of Pulmonary/Respiratory Drug Delivery Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Pulmonary/Respiratory Drug Delivery by Major End-Users
-
4.4.1 Market Size and Growth Rate of Pulmonary/Respiratory Drug Delivery in Hospitals
-
4.4.2 Market Size and Growth Rate of Pulmonary/Respiratory Drug Delivery in Home Care
5 Market Analysis by Regions
-
5.1 China Pulmonary/Respiratory Drug Delivery Production Analysis by Regions
-
5.2 China Pulmonary/Respiratory Drug Delivery Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Pulmonary/Respiratory Drug Delivery Landscape Analysis
-
6.1 North China Pulmonary/Respiratory Drug Delivery Landscape Analysis by Major Types
-
6.2 North China Pulmonary/Respiratory Drug Delivery Landscape Analysis by Major End-Users
7 Central China Pulmonary/Respiratory Drug Delivery Landscape Analysis
-
7.1 Central China Pulmonary/Respiratory Drug Delivery Landscape Analysis by Major Types
-
7.2 Central China Pulmonary/Respiratory Drug Delivery Landscape Analysis by Major End-Users
8 South China Pulmonary/Respiratory Drug Delivery Landscape Analysis
-
8.1 South China Pulmonary/Respiratory Drug Delivery Landscape Analysis by Major Types
-
8.2 South China Pulmonary/Respiratory Drug Delivery Landscape Analysis by Major End-Users
9 East China Pulmonary/Respiratory Drug Delivery Landscape Analysis
-
9.1 East China Pulmonary/Respiratory Drug Delivery Landscape Analysis by Major Types
-
9.2 East China Pulmonary/Respiratory Drug Delivery Landscape Analysis by Major End-Users
10 Northeast China Pulmonary/Respiratory Drug Delivery Landscape Analysis
-
10.1 Northeast China Pulmonary/Respiratory Drug Delivery Landscape Analysis by Major Types
-
10.2 Northeast China Pulmonary/Respiratory Drug Delivery Landscape Analysis by Major End-Users
11 Southwest China Pulmonary/Respiratory Drug Delivery Landscape Analysis
-
11.1 Southwest China Pulmonary/Respiratory Drug Delivery Landscape Analysis by Major Types
-
11.2 Southwest China Pulmonary/Respiratory Drug Delivery Landscape Analysis by Major End-Users
12 Northwest China Pulmonary/Respiratory Drug Delivery Landscape Analysis
-
12.1 Northwest China Pulmonary/Respiratory Drug Delivery Landscape Analysis by Major Types
-
12.2 Northwest China Pulmonary/Respiratory Drug Delivery Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 GlaxoSmithKline (UK)
-
13.1.1 GlaxoSmithKline (UK) Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Novartis AG (Switzerland)
-
13.2.1 Novartis AG (Switzerland) Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Merck & Co, Inc (US)
-
13.3.1 Merck & Co, Inc (US) Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 AstraZeneca plc (UK)
-
13.4.1 AstraZeneca plc (UK) Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 3M (US)
-
13.5.1 3M (US) Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Omron Corporation (Japan)
-
13.6.1 Omron Corporation (Japan) Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Boehringer Ingelheim GmbH (Germany)
-
13.7.1 Boehringer Ingelheim GmbH (Germany) Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Sunovion Pharmaceuticals Inc (US)
-
13.8.1 Sunovion Pharmaceuticals Inc (US) Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Teva Pharmaceutical Industries Ltd (Israel)
-
13.9.1 Teva Pharmaceutical Industries Ltd (Israel) Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Pulmonary/Respiratory Drug Delivery Market Size and Growth Rate of Suspension Aerosol from 2016 to 2027
-
Figure China Pulmonary/Respiratory Drug Delivery Market Size and Growth Rate of Solution Aerosol from 2016 to 2027
-
Figure China Pulmonary/Respiratory Drug Delivery Market Size and Growth Rate of Dry Powder Formulation from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Pulmonary/Respiratory Drug Delivery Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Pulmonary/Respiratory Drug Delivery Market Size and Growth Rate of Home Care from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Pulmonary/Respiratory Drug Delivery Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Pulmonary/Respiratory Drug Delivery Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Pulmonary/Respiratory Drug Delivery Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Pulmonary/Respiratory Drug Delivery Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Pulmonary/Respiratory Drug Delivery Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Pulmonary/Respiratory Drug Delivery Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Pulmonary/Respiratory Drug Delivery Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Pulmonary/Respiratory Drug Delivery Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Pulmonary/Respiratory Drug Delivery
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Pulmonary/Respiratory Drug Delivery by Different Types from 2016 to 2027
-
Table Consumption Share of Pulmonary/Respiratory Drug Delivery by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Suspension Aerosol
-
Figure Market Size and Growth Rate of Solution Aerosol
-
Figure Market Size and Growth Rate of Dry Powder Formulation
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Pulmonary/Respiratory Drug Delivery by Different End-Users from 2016 to 2027
-
Table Consumption Share of Pulmonary/Respiratory Drug Delivery by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Home Care
-
Table China Pulmonary/Respiratory Drug Delivery Production by Regions
-
Table China Pulmonary/Respiratory Drug Delivery Production Share by Regions
-
Figure China Pulmonary/Respiratory Drug Delivery Production Share by Regions in 2016
-
Figure China Pulmonary/Respiratory Drug Delivery Production Share by Regions in 2021
-
Figure China Pulmonary/Respiratory Drug Delivery Production Share by Regions in 2027
-
Table China Pulmonary/Respiratory Drug Delivery Consumption by Regions
-
Table China Pulmonary/Respiratory Drug Delivery Consumption Share by Regions
-
Figure China Pulmonary/Respiratory Drug Delivery Consumption Share by Regions in 2016
-
Figure China Pulmonary/Respiratory Drug Delivery Consumption Share by Regions in 2021
-
Figure China Pulmonary/Respiratory Drug Delivery Consumption Share by Regions in 2027
-
Table North China Pulmonary/Respiratory Drug Delivery Consumption by Types from 2016 to 2027
-
Table North China Pulmonary/Respiratory Drug Delivery Consumption Share by Types from 2016 to 2027
-
Figure North China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2016
-
Figure North China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2021
-
Figure North China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2027
-
Table North China Pulmonary/Respiratory Drug Delivery Consumption by End-Users from 2016 to 2027
-
Table North China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users from 2016 to 2027
-
Figure North China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2016
-
Figure North China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2021
-
Figure North China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2027
-
Table Central China Pulmonary/Respiratory Drug Delivery Consumption by Types from 2016 to 2027
-
Table Central China Pulmonary/Respiratory Drug Delivery Consumption Share by Types from 2016 to 2027
-
Figure Central China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2016
-
Figure Central China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2021
-
Figure Central China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2027
-
Table Central China Pulmonary/Respiratory Drug Delivery Consumption by End-Users from 2016 to 2027
-
Table Central China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2016
-
Figure Central China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2021
-
Figure Central China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2027
-
Table South China Pulmonary/Respiratory Drug Delivery Consumption by Types from 2016 to 2027
-
Table South China Pulmonary/Respiratory Drug Delivery Consumption Share by Types from 2016 to 2027
-
Figure South China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2016
-
Figure South China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2021
-
Figure South China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2027
-
Table South China Pulmonary/Respiratory Drug Delivery Consumption by End-Users from 2016 to 2027
-
Table South China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users from 2016 to 2027
-
Figure South China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2016
-
Figure South China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2021
-
Figure South China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2027
-
Table East China Pulmonary/Respiratory Drug Delivery Consumption by Types from 2016 to 2027
-
Table East China Pulmonary/Respiratory Drug Delivery Consumption Share by Types from 2016 to 2027
-
Figure East China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2016
-
Figure East China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2021
-
Figure East China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2027
-
Table East China Pulmonary/Respiratory Drug Delivery Consumption by End-Users from 2016 to 2027
-
Table East China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users from 2016 to 2027
-
Figure East China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2016
-
Figure East China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2021
-
Figure East China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2027
-
Table Northeast China Pulmonary/Respiratory Drug Delivery Consumption by Types from 2016 to 2027
-
Table Northeast China Pulmonary/Respiratory Drug Delivery Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2016
-
Figure Northeast China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2021
-
Figure Northeast China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2027
-
Table Northeast China Pulmonary/Respiratory Drug Delivery Consumption by End-Users from 2016 to 2027
-
Table Northeast China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2016
-
Figure Northeast China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2021
-
Figure Northeast China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2027
-
Table Southwest China Pulmonary/Respiratory Drug Delivery Consumption by Types from 2016 to 2027
-
Table Southwest China Pulmonary/Respiratory Drug Delivery Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2016
-
Figure Southwest China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2021
-
Figure Southwest China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2027
-
Table Southwest China Pulmonary/Respiratory Drug Delivery Consumption by End-Users from 2016 to 2027
-
Table Southwest China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2016
-
Figure Southwest China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2021
-
Figure Southwest China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2027
-
Table Northwest China Pulmonary/Respiratory Drug Delivery Consumption by Types from 2016 to 2027
-
Table Northwest China Pulmonary/Respiratory Drug Delivery Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2016
-
Figure Northwest China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2021
-
Figure Northwest China Pulmonary/Respiratory Drug Delivery Consumption Share by Types in 2027
-
Table Northwest China Pulmonary/Respiratory Drug Delivery Consumption by End-Users from 2016 to 2027
-
Table Northwest China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2016
-
Figure Northwest China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2021
-
Figure Northwest China Pulmonary/Respiratory Drug Delivery Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of GlaxoSmithKline (UK)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline (UK)
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline (UK)
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline (UK)
-
Table Product and Service Introduction of GlaxoSmithKline (UK)
-
Table Company Profile and Development Status of Novartis AG (Switzerland)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Switzerland)
-
Figure Sales and Growth Rate Analysis of Novartis AG (Switzerland)
-
Figure Revenue and Market Share Analysis of Novartis AG (Switzerland)
-
Table Product and Service Introduction of Novartis AG (Switzerland)
-
Table Company Profile and Development Status of Merck & Co, Inc (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co, Inc (US)
-
Figure Sales and Growth Rate Analysis of Merck & Co, Inc (US)
-
Figure Revenue and Market Share Analysis of Merck & Co, Inc (US)
-
Table Product and Service Introduction of Merck & Co, Inc (US)
-
Table Company Profile and Development Status of AstraZeneca plc (UK)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca plc (UK)
-
Figure Sales and Growth Rate Analysis of AstraZeneca plc (UK)
-
Figure Revenue and Market Share Analysis of AstraZeneca plc (UK)
-
Table Product and Service Introduction of AstraZeneca plc (UK)
-
Table Company Profile and Development Status of 3M (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3M (US)
-
Figure Sales and Growth Rate Analysis of 3M (US)
-
Figure Revenue and Market Share Analysis of 3M (US)
-
Table Product and Service Introduction of 3M (US)
-
Table Company Profile and Development Status of Omron Corporation (Japan)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Omron Corporation (Japan)
-
Figure Sales and Growth Rate Analysis of Omron Corporation (Japan)
-
Figure Revenue and Market Share Analysis of Omron Corporation (Japan)
-
Table Product and Service Introduction of Omron Corporation (Japan)
-
Table Company Profile and Development Status of Boehringer Ingelheim GmbH (Germany)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim GmbH (Germany)
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim GmbH (Germany)
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim GmbH (Germany)
-
Table Product and Service Introduction of Boehringer Ingelheim GmbH (Germany)
-
Table Company Profile and Development Status of Sunovion Pharmaceuticals Inc (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sunovion Pharmaceuticals Inc (US)
-
Figure Sales and Growth Rate Analysis of Sunovion Pharmaceuticals Inc (US)
-
Figure Revenue and Market Share Analysis of Sunovion Pharmaceuticals Inc (US)
-
Table Product and Service Introduction of Sunovion Pharmaceuticals Inc (US)
-
Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd (Israel)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd (Israel)
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd (Israel)
-
Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd (Israel)
-
Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd (Israel)
-
